Drug Quality in China Still Poses Risks for U.S. Market

Improvements are needed in the production of drug ingredients in China to erase the safety risks faced by American consumers, the top U.S. pharmaceutical regulator for the Asian country said.

While the Food and Drug Administration attempts to ensure medicines imported from China are safe, regulators are pressing the country’s drug industry to raise quality, Christopher Hickey, director of the FDA’s China office, said at a hearing yesterday in Washington.